Where are the Cures? Accelerating New Treatments for Multiple Sclerosis & All Diseases

With over $139 billion U.S. dollars invested in medical research each year-a number expected to increase-only 30 new drugs reached patients in 2011. Learn how Silicon Valley entrepreneur Scott Johnson, also a multiple sclerosis patient for 36 years, became an unlikely revolutionary to reform the medical research system that has failed to produce new patient treatments for millions living with chronic and debilitating diseases.

Scott Johnson, who has been living with multiple sclerosis since 1976, is using his acumen as a business consultant and serial entrepreneur to reform a system for medical research and drug development that has failed to produce new patient treatments for millions living with chronic and debilitating diseases.He holds an M.B.A. from the University of California, Berkeley Haas School of Business and a B.S. in Civil Engineering from the University of California, Davis.

Speaker: Scott Johnson, CEO, Myelin Repair Foundation